Tilray Shares Face Mounting Pressure as US Regulatory Shift Unfolds
Published on 11/16/2025 at 04:42 | Redaktion boerse-global.de
The Canadian cannabis producer Tilray is confronting intensified selling pressure as a recent legislative change in the United States casts a shadow over its strategic ambitions. This development represents a significant obstacle for the company’s long-term plans to expand within the US market.
Friday’s trading session saw Tilray shares decline by 4.42% to close at $1.08, marking the second consecutive day of substantial losses. Trading activity surged 18% above average levels as investors exited positions, reflecting heightened market anxiety.
The downturn was triggered by a late addition to a US federal budget bill that effectively re-criminalizes certain popular hemp-derived THC products, including Delta-8 THC. These products had operated in a Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
